First biomarker could help boys at risk of major depression

By Kate Kelland LONDON (Reuters) – British brain scientists have identified the first biomarker, or biological signpost, for clinical depression and say it could help find boys in particular who are at risk of developing the debilitating mental illness. In a study in the Proceedings of the National Academies of Science (PNAS) journal, the team found that teenage boys who have a combination of depressive symptoms and raised levels of the stress hormone cortisol are up to 14 times more likely to develop major depression than those who show neither trait. “We’re very bad about looking after our mental health, and yet the problems of mental health are extremely common,” said Barbara Sahakian, a Cambridge University professor of Clinical neuropsychology who worked on the study. “(And) we now have a very real way of identifying those teenage boys most likely to develop clinical depression.” He said armed with such knowledge, doctors and other carers could target prevention strategies at depression-vulnerable boys and “hopefully help reduce their risk of serious episodes of depression and their consequences in adult life”.

Kids who use snus before age 16 more likely to become smokers

By Shereen Jegtvig NEW YORK (Reuters Health) – Norwegians who started using snus before age 16 were more likely to become cigarette smokers than those who started using snus later in life, according to a new study. Snus is moist smokeless tobacco developed in Sweden. It’s contained in a small pouch, and unlike regular chewing tobacco, it doesn’t make the user spit. Research suggests snus has lower levels of chemicals called nitrosamines than cigarettes and may be less harmful.

‘World’s first mask for polyphasic sleep’ to launch

Screenshot: NeuroOn || KickStarterSleep masks can be great if you want to improve the quality of your Zs, but a new nighttime accessory claims to go one step further by reducing the number of hours' sleep you need per day. NeuroOn is being billed as the world's first brain wave-monitoring sleep mask that helps wearers switch to polyphasic sleep patterns. According to its designers, polyphasic sleepers need as little as two-to-six hours of sleep per day, which could create an extra 28 hours of free time each week.

Big tobacco returns to British TV with BAT e-cig advert

British American Tobacco will become the biggest tobacco company to show a television advert for e-cigarettes in Britain on Monday but will leave out any reference to ‘smokers’ to comply with laws which ban the promotion of tobacco products. Soaring sales of e-cigarettes, metal tubes with batteries which heat nicotine-laced liquids into a vapor, have caught the eye of some of the world’s biggest tobacco companies including BAT, Altria Group and Imperial Tobacco. A consultation into the rules governing e-cigarette advertising is due to be launched shortly by UK regulators governing print, online and broadcast advertising but BAT said the current rules left e-cigarette advertising unclear. E-cigarettes are seen as less harmful than regular cigarettes and a useful way to wean smokers off their habits but critics say they can act as a gateway to nicotine addiction and that more research is needed on the health implications.

Months after rehab, knee and hip patients keep improving

A worker tries on a prosthetic leg for a patient at the Center of Advanced Prosthetics in San JoseBy Kathleen Raven NEW YORK (Reuters Health) – People who have had a knee or hip replacement reap the benefits of intense rehab months after they've returned home, according to a new analysis. "If you can get patients to a certain threshold level, they can do the rest of the rehabilitation on their own," coauthor Kenneth Ottenbacher told Reuters Health. Ottenbacher directs the Center for Rehabilitation Sciences at The University of Texas Medical Branch in Galveston. He and his team analyzed data from 12,199 U.S. patients who underwent knee or hip replacement between 2008 and 2010.

1 868 869 870 871 872 1,024